Last reviewed · How we verify
Staphylococcus Aureus Complicated UTI
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Tobi · Novartis
- Vantobra · Pfizer
- Nebcin · University Hospital, Lille
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Staphylococcus Aureus Complicated UTI patent landscape — cliff calendar, originator estates, attackable patents
- Staphylococcus Aureus Complicated UTI treatment landscape brief
- Staphylococcus Aureus Complicated UTI treatment updates RSS
Frequently asked questions about Staphylococcus Aureus Complicated UTI
What drugs treat Staphylococcus Aureus Complicated UTI?
Tracked treatments include Ramycin, Tobi, Vantobra, Nebcin.
What is the treatment for Staphylococcus Aureus Complicated UTI?
Standard treatment for Staphylococcus Aureus Complicated UTI includes Ramycin, Tobi, Vantobra, Nebcin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Staphylococcus Aureus Complicated UTI patent cliff · Staphylococcus Aureus Complicated UTI CI report
- Treatment: Ramycin
- Treatment: Tobi · Novartis
- Treatment: Vantobra · Pfizer
- Treatment: Nebcin · University Hospital, Lille
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing